HCA Healthcare (NYSE:HCA) EVP Michael Mcalevey Sells 1,694 Shares

HCA Healthcare, Inc. (NYSE:HCA) EVP Michael Mcalevey sold 1,694 shares of the business’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

HCA Healthcare Trading Up 0.0%

NYSE:HCA traded up $0.10 during midday trading on Wednesday, hitting $534.88. 802,561 shares of the stock were exchanged, compared to its average volume of 1,140,630. The business has a 50-day moving average price of $484.82 and a two-hundred day moving average price of $452.18. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $552.90. The company has a market capitalization of $119.61 billion, a price-to-earnings ratio of 18.85, a P/E/G ratio of 1.66 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the firm posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HCA. Jefferies Financial Group increased their price objective on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. TD Cowen reissued a “buy” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. Oppenheimer upped their target price on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Zacks Research downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $523.27.

Institutional Trading of HCA Healthcare

Hedge funds have recently modified their holdings of the company. Brighton Jones LLC bought a new position in HCA Healthcare in the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC raised its stake in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the last quarter. Chicago Partners Investment Group LLC grew its position in shares of HCA Healthcare by 228.2% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 3,092 shares of the company’s stock worth $1,092,000 after buying an additional 2,150 shares during the period. Finally, Stephens Inc. AR boosted its stake in HCA Healthcare by 3.2% during the 2nd quarter. Stephens Inc. AR now owns 8,500 shares of the company’s stock worth $3,256,000 after acquiring an additional 265 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.